IDRA-21 was developed around 1994 or 1995 and is not as well-researched as other nootropics. IDRA-21, however, was rapidly absorbed into the Nootropika community. Classified as Ampakin, IDRA-21 is able to facilitate focus, attention and learning. Mainly it gains in popularity by its enormous effect to increase the memory performance. By comparison, IDRA-21 is 10-30 times more potent than aniracetam. IDRA-21 was originally used to reverse cognitive deficits caused by scopolamine and alprazolam.

Dosage

One dose of IDRA-21 may last up to 3 days. It is difficult to say what doses are suitable for humans. However, nootropics advise consumers to take a maximum of 5-25 mg.

Pile

IDRA-21 should not be taken with other ampakine medicines, such as aniracetam. Nootropics that increase glutamate levels should be avoided in conjunction with IDRA-21.

Side effects

In general, IDRA-21 is considered to be a safe supplement. However, there is a lack of meaningful studies. The dosage should therefore be low and carefully increased.

Warning

IDRA-21 should be avoided at all times in patients prone to strokes or strokes. People who suffer from seizures should also not consume IDRA-21.

IDRA-21 Reviews (1)